Red cell-mediated therapy: opportunities and challenges.

Red blood cells have unique properties that offer attractive therapeutic possibilities. It is proposed that by covalently linking drug pharmacophores to red cell surface proteins, significant enhancement of pharmacokinetics can be achieved. Specific anchoring to erythrocytes can be accomplished in principle, using unique, affinity labeling, combinatorial libraries targeting the surface protein, glycophorin A. The anticipated advantages of red cell-anchored drugs over free drugs, include extended half-lives, controlled volumes of distribution, and multivalent interactions.

[1]  V. Muzykantov,et al.  Red blood cell targeting to collagen‐coated surfaces , 1983, FEBS letters.

[2]  A. Vignal,et al.  Alteration of the genes for glycophorin A and B in glycophorin-A-deficient individuals. , 1988, European journal of biochemistry.

[3]  M. Rędowicz,et al.  Temperature-dependent conformational transition in the head-rod junctional region of the myosin molecule. , 1988, European journal of biochemistry.

[4]  Schrier Sl.  Red cell membrane biology--introduction. , 1985 .

[5]  P. Low,et al.  Methodologic considerations for the use of canine in vivo aged biotinylated erythrocytes to study RBC senescence. , 1996, Experimental hematology.

[6]  J. Walder,et al.  Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site. , 1984, The Journal of biological chemistry.

[7]  B. Coller,et al.  Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. , 1992, Journal of Clinical Investigation.

[8]  V. Marchesi,et al.  Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence. , 1978, Biochemistry.

[9]  M. Magnani,et al.  The Use of Resealed Erythrocytes as Carriers and Bioreactors , 1992, Advances in Experimental Medicine and Biology.

[10]  R. Hillman,et al.  Red cell manual , 1974 .

[11]  N. Mohandas,et al.  Signal transduction by glycophorin A: role of extracellular and cytoplasmic domains in a modulatable process , 1988, The Journal of cell biology.

[12]  T. Suzuki,et al.  Biotinylated erythrocytes: in vivo survival and in vitro recovery , 1987 .

[13]  M. Wilchek,et al.  The avidin-biotin complex in bioanalytical applications. , 1988, Analytical biochemistry.

[14]  V. Muzykantov,et al.  Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Katzung.  Basic and Clinical Pharmacology , 1982 .

[16]  V. Muzykantov,et al.  Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot. , 1986, Biochimica et biophysica acta.

[17]  L. Huang,et al.  The role of multivalency in antibody mediated liposome targeting. , 1987, Biochemical and biophysical research communications.

[18]  P. Bartlett,et al.  Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range. , 1991, Biochemistry.

[19]  M. Powell.  Chapter 30. Peptide Stability in Drug Development: in vitro Peptide Degradation in Plasma and Serum , 1993 .